Schonfeld Strategic Advisors LLC Intra Cellular Therapies, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 134,454 shares of ITCI stock, worth $10.4 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
134,454
Previous 24,418
450.63%
Holding current value
$10.4 Million
Previous $1.69 Million
445.17%
% of portfolio
0.06%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ITCI
# of Institutions
399Shares Held
87.5MCall Options Held
309KPut Options Held
302K-
Vanguard Group Inc Valley Forge, PA9.61MShares$741 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$487 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$287 Million1.37% of portfolio
-
Jpmorgan Chase & CO New York, NY3.44MShares$265 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$231 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $7.28B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...